The Weekly Checkup

The Weekly Checkup

Every Tuesday morning we deliver healthcare M&A news, deals on the market, and valuation insights.

The Weekly Checkup: Week of November 9-13, 2026

Nov 17, 2026

•

14 min read

The Weekly Checkup: Week of November 9-13, 2026

Ardent pays a dime per dollar of revenue for Boone, Charles River’s earnout hints at a 36% margin for Frontage's PA labs, and a $125m DME platform "on the market."

Will Hamilton
Will Hamilton
The Weekly Checkup: Week of November 2-6, 2026

Nov 10, 2026

•

15 min read

The Weekly Checkup: Week of November 2-6, 2026

77 announced deals: Bertram pays 20x for a medical gas tester, Lonza buys Merck’s US plants for half what one cost, a Korean sponsor tripled its money in two years, the Walgreens breakup reaches CareCentrix, and Ares shops its Duly stake.

Will Hamilton
Will Hamilton
The Weekly Checkup: Week of October 26-30, 2026

Nov 3, 2026

•

14 min read

The Weekly Checkup: Week of October 26-30, 2026

Bon Secours Mercy pays $5.7b for Surgery Partners (~13.8x, not ~10.8x), RadNet’s $910 million teleradiology bet, an odd approach to comp selection in the Option Care fairness opinion, and a bunch of pain management listings.

Will Hamilton
Will Hamilton
The Weekly Checkup: Week of October 19, 2026

Oct 27, 2026

•

16 min read

The Weekly Checkup: Week of October 19, 2026

70 deals! The distributors keep buying doctors, Labcorp signs its second lab deal in a week, and a $450 million hospital that is 5.7x or 18.9x EBITDA depending on the definition.

Will Hamilton
Will Hamilton
The Weekly Checkup: Week of October 12-16, 2026

Oct 20, 2026

•

12 min read

The Weekly Checkup: Week of October 12-16, 2026

STERIS pays $2.1 billion for a surgical pad with a 55% margin, what a lab biz losing $13 million a quarter is worth to Labcorp, and Humana trades Welsh Carson for BlackRock (and a put for a floor) at CenterWell.

Will Hamilton
Will Hamilton
The Weekly Checkup: Week of October 5-9, 2026

Oct 13, 2026

•

13 min read

The Weekly Checkup: Week of October 5-9, 2026

McKesson buys 49% of the biggest home infusion company with a path to the rest, two pieces of the old Walgreens empire change hands, and a VA exam clinic netting 73% with every contract expiring in December

Will Hamilton
Will Hamilton
Load more